Angion Biomedica

Developer of organ restoration therapies with a focus on renal diseases

placeUniondale, New York, United States calendar_todayFounded 1998 groups71 employees language angion.com

Registered entities

Innovation

45 patent families (14 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 2,497 times.

YearFilings
20137
201412
20157
20167
20176
20186
20198
20206
202111
202215
20238
20241

Investor mix

5 investors on record; lead investors include Alpine Bioventures.

Investor typeCountShare
Venture capital360%
Other / undisclosed240%
Coming soon